Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons

被引:11
作者
Aronow, WS
机构
[1] Hebrew Hosp Home, Dept Med, Bronx, NY 10475 USA
[2] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA
来源
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 2001年 / 137卷 / 05期
关键词
D O I
10.1067/mlc.2001.114106
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Underlying causes and precipitating causes of congestive heart failure (CHF) should be treated when possible. Older persons with CHF and normal left ventricular (LV) ejection fraction should have maintenance of sinus rhythm, treatment of hypertension and myocardial ischemia, slowing of the ventricular rate below 90 beats/minute, and reduction of salt overload. First-line drug treatment in the management of these persons is the use of loop diuretics combined with beta blockers as tolerated. Angiotensin-converting enzyme (ACE) inhibitors should be administered if CHF persists despite diuretics and beta blockers. If persons are unable to tolerate ACE inhibitors because of cough, rash, or altered taste sensation, angiotensin II type 1 receptor antagonists should be given. If CHF persists despite diuretics, beta blockers, and ACE inhibitors or the person is unable to tolerate beta blockers, ACE inhibitors, and angiotensin II type 1 receptor antagonists, isosorbide dinitrate plus hydralazine should be administered. Calcium channel blockers should be used if CHF persists despite administration of diuretics and the person is unable to tolerate beta blockers, ACE inhibitors, angiotensin II type 1 receptor antagonists, and isosorbide dinitrate plus hydralazine. Digoxin, beta blockers, verapamil, and diltiazem may be used to slow a rapid ventricular rate in persons with supraventricular tachyarrhythmias. Digoxin should not be used in persons with CHF in sinus rhythm with normal LV ejection fraction.
引用
收藏
页码:316 / 323
页数:8
相关论文
共 61 条
[1]  
American Medical Directors Association, 1996, HEART FAIL CLIN PRAC, P1
[2]  
[Anonymous], 1994, Clin Pract Guidel Quick Ref Guide Clin, P1
[3]  
ARONOW W S, 1991, Drugs and Aging, V1, P98, DOI 10.2165/00002512-199101020-00002
[4]   EFFECT OF PROPRANOLOL VERSUS NO ANTIARRHYTHMIC DRUG ON SUDDEN CARDIAC DEATH, TOTAL CARDIAC DEATH, AND TOTAL DEATH IN PATIENTS GREATER-THAN-OR-EQUAL-TO-62-PERCENT YEARS OF AGE WITH HEART-DISEASE, COMPLEX VENTRICULAR ARRHYTHMIAS, AND LEFT-VENTRICULAR EJECTION FRACTION GREATER-THAN-OR-EQUAL-TO-40-PERCENT [J].
ARONOW, WS ;
AHN, C ;
MERCANDO, AD ;
EPSTEIN, S ;
KRONZON, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (03) :267-270
[5]   Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (11) :1382-+
[6]   Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction >=40% treated with diuretics plus angiotensin-converting enzyme inhibitors [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02) :207-209
[7]   Normal left ventricular ejection fraction in older persons with congestive heart failure [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I .
CHEST, 1998, 113 (04) :867-869
[8]   Comparison of incidences congestive heart failure in older African-Americans, Hispanics and whites [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (05) :611-+
[9]   EFFECT OF ENALAPRIL ON CONGESTIVE-HEART-FAILURE TREATED WITH DIURETICS IN ELDERLY PATIENTS WITH PRIOR MYOCARDIAL-INFARCTION AND NORMAL LEFT-VENTRICULAR EJECTION FRACTION [J].
ARONOW, WS ;
KRONZON, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (07) :602-604
[10]   PROGNOSIS OF CONGESTIVE-HEART-FAILURE IN ELDERLY PATIENTS WITH NORMAL VERSUS ABNORMAL LEFT-VENTRICULAR SYSTOLIC FUNCTION ASSOCIATED WITH CORONARY-ARTERY DISEASE [J].
ARONOW, WS ;
AHN, C ;
KRONZON, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (17) :1257-1259